OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
September 30, 2026 — OS Therapies reports 75% 2-year survival in osteosarcoma trial, plans regulatory filings for OST-HER2 with FDA and UK MHRA by year-end 2025.
NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
September 30, 2026 — OS Therapies reports 75% 2-year survival in osteosarcoma trial, plans regulatory filings for OST-HER2 with FDA and UK MHRA by year-end 2025.
September 30, 2026 — OS Therapies advances OST-HER2 immunotherapy for osteosarcoma with FDA RMAT designation. Phase 2b results show significant survival improvement. Potential 2026 launch with commercial partner Eversana.
May 31, 2026 — Cingulate advances CTx-1301 ADHD treatment with FDA acceptance and 2026 PDUFA date. Stonegate updates coverage as company prepares for potential commercial launch.
January 1, 2026 — BioUtah announces new board leadership with Erin Barry as chair and Andrew Hemmert as vice chair, plus three new board members. Changes take effect January 2026 for Utah's life sciences trade association.
December 7, 2025 — Discover expert Botox treatments at Laser Center of Marin in Corte Madera, CA. Achieve natural, youthful results without surgery, addressing wrinkles, TMJ, and more. Book a consultation today!
December 7, 2025 — Esthetics Center offers natural injectable treatments like BOTOX and fillers, led by Dr. Reginald Rice. Boost confidence with personalized plans at multiple locations.
December 7, 2025 — Anne Therese Aesthetic Medicine introduces advanced laser hair removal in Lewis Center, OH, offering long-lasting hair reduction with minimal downtime. Book your consultation today.
December 6, 2025 — Dr. Guy Navarra Scholarship offers $1,000 to undergraduate pre-med students. Apply by April 15, 2026 with essay on future healthcare impact. Supports next generation of medical professionals.
December 6, 2025 — Wayne Cohen of Cohen Injury Law Group shares three key steps to take after a car or truck accident to protect health and legal rights. Learn how to preserve evidence and find the right attorney for compensation.
December 6, 2025 — Dr. Wendell Bulmer Scholarship for Future Physicians now accepting applications from undergraduate students nationwide. Focus on osteopathic principles and holistic patient care. Deadline June 15, 2026.
December 6, 2025 — NobleSpirit auctions 14 newly discovered Civil War letters by surgeon Dr. David Cheever, featuring rare account of Lincoln hospital visit. Historic medical documents reveal wartime medicine and presidential history.
December 5, 2025 — Whole Health Everyday marks 15 years of personalized chef meal prep with wellness-driven menus, Michelin-starred influence, and expansion plans. Learn about their gourmet nutrition services.
December 5, 2025 — Soligenix advances rare disease therapies like HyBryte™ for CTCL, featured in BioMedWire editorial on aging populations and unmet medical needs. Explore their late-stage programs and impact.
December 5, 2025 — Belite Bio prices $350M public offering to fund retinal disease therapies like Tinlarebant for Stargardt disease and AMD, managed by Morgan Stanley and other top firms.
December 5, 2025 — Washington University researchers develop nasal drops to combat glioblastoma, a deadly brain cancer, with potential to enhance treatment efficacy through direct CNS delivery.
December 5, 2025 — Centerport Cosmetic & Implant Dentistry in Portland offers advanced dental care with Dr. Benjamin Wang. Services include dental implants, veneers, and smile makeovers for a confident, healthy smile.
December 4, 2025 — CNS Pharmaceuticals advances Berubicin to treat glioblastoma by overcoming the blood-brain barrier. Learn about this clinical-stage company's mission to combat deadly brain cancer.
December 4, 2025 — Oncotelic Therapeutics announces biomarker predicting tumor sensitivity to Sapu003 cancer drug. Breakthrough based on 9,000+ tumor samples could transform treatment for breast, lung & other cancers.
December 4, 2025 — VolitionRx's Nu.Q® H3.1 assay selected for France's DETECSEPS sepsis detection program, aiming to improve emergency care with rapid results and better outcomes.
December 4, 2025 — AdipoLABs expands in Asia-Pacific with University of Cyberjaya partnership, offering internships, clinical research, and Pain Bot technology training to advance MedTech innovation in Malaysia.